Melanoma, Stage II
10 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression) (NCT05135715) | RemeGen Co., Ltd. | 2022-04-19 |
| Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice (NCT05402059) | MelanomaPRO, Russia | 2022-03-02 |
| Circulating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resecTION (NCT04901988) | The Christie NHS Foundation Trust | 2021-11-08 |
| Exploring Unmet Needs and Attitudes to Skin Self-examination in Melanoma Survivors (NCT04675346) | Oxford University Hospitals NHS Trust | 2020-11-18 |
| Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors (NCT04990726) | M.D. Anderson Cancer Center | 2019-12-05 |
| Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin (NCT07671495) | MIPO Clinic | 2014-01-01 |
Track Melanoma, Stage II automatically
Every clearance here is in the API, with alerts when new ones post.